Vaccinex Announces Pricing of $9.6 Million Public Offering ROCHESTER, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...

22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference BUFFALO, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

VERB Management to Discuss Company’s Application Solutions for the Growing Livestream Ecommerce Market at A.G.P.’s Tech Talk Webinar on Thursday, June 10, 2021, at 11:00 a.m. ET Microsoft Outlook Integration of VERB’s interactive video sales technology set for commercial release in mid-June among Company’s leading revenue catalysts Company reported Q1 2021 SaaS recurring...

Entasis Therapeutics to Participate in A.G.P.’s Virtual Healthcare Symposium WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...

Professional Diversity Network Announces $2 Million Registered Direct Offering CHICAGO, July 27, 2020 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (Nasdaq: IPDN), today announced it has entered into definitive agreements with institutional investors for the...